The omicron vaccine will be ready in March

The omicron vaccine will be ready in March
Pfizer CEO Albert Bourla said Monday that a vaccine to protect against the omicron variant will be ready in March and the company has already started producing doses.

Bourla also stated that the vaccine will also target other variants circulating. He said it is not yet clear whether or not an omicron vaccine is needed or how it will be used, but Pfizer will have several doses ready as some countries want it as soon as possible.

Data from the UK have shown that Pfizer and Moderna vaccines are only about 10% effective in preventing symptomatic infection from omicron 20 weeks after the second dose, according to the study by the UK Health and Safety Agency. However, the two original doses still offer good protection against serious diseases, the study found.

According to the study, booster vaccines are up to 75% effective in preventing symptomatic infection.